Skip to main content
. 2023 Aug 10;12:e63402. doi: 10.7554/eLife.63402

Table 2. Sclerostin small-molecule inhibitors (SMIs) increase posterolateral spinal fusion rates.

Table 2—source data 1. Source data for Table 2.
Fusion rate (%)
ICBG 66
VA1 + ICBG 80
C07 + ICBG 83
Control 0
VA1 17
C07 33
Control 0
VA1 –
C07 80